Literature DB >> 18047032

Myelopeptide-5 is a novel endogenous immunoregulator recovering the functional activity of T-lymphocytes.

R G Belevskaya1, M V Kalyuzhnaya, L A Fonina, A A Mikhailova, R V Petrov.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18047032     DOI： 10.1134/s0012496607050249

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  6 in total

1.  Measles virus-induced suppression of lymphocyte proliferation.

Authors:  M Sanchez-Lanier; P Guerin; L C McLaren; A D Bankhurst
Journal:  Cell Immunol       Date:  1988-10-15       Impact factor: 4.868

2.  Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer.

Authors:  B C Sheu; R H Lin; H C Lien; H N Ho; S M Hsu; S C Huang
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

3.  [Tumor-induced immunosuppression].

Authors:  S Paul; B Calmels; E Régulier
Journal:  Ann Biol Clin (Paris)       Date:  2002 Mar-Apr       Impact factor: 0.459

4.  Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes.

Authors:  S Miescher; T L Whiteside; S Carrel; V von Fliedner
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

5.  Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor.

Authors:  J W Chiao; M Heil; Z Arlin; J D Lutton; Y S Choi; K Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection.

Authors:  Sharookh B Kapadia; Beth Levine; Samuel H Speck; Herbert W Virgin
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.